EPAS1 and metabolic dysfunction-associated steatohepatitis: A study by Foglia et al. [59] highlighted that a specific deletion of HIF-2α in a rodent model of MASH-related liver carcinogenesis led to a significant reduction in volume and number of liver tumors vs. controls.